Home > Financial Ratios > DR LAL PATHLABS

DR LAL PATHLABS
Core EBITDA Growth

    Back to All Ratios
DR LAL PATHLABS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

DR LAL PATHLABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 16.3127.63-13.3225.7722.32

What is the latest Core EBITDA Growth ratio of DR LAL PATHLABS ?

The latest Core EBITDA Growth ratio of DR LAL PATHLABS is 16.31 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202516.31
Mar202427.63
Mar2023-13.32
Mar202225.77
Mar202122.32

How is Core EBITDA Growth of DR LAL PATHLABS Trending?

Years Core EBITDA Growth % Change
Mar2025 16.31
-40.97
Mar2024 27.63
Positive
Mar2023 -13.32
Negative
Mar2022 25.77
15.46
Mar2021 22.32 -

Other Financial Ratios of DR LAL PATHLABS


Compare Core EBITDA Growth ratio of peers of DR LAL PATHLABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DR LAL PATHLABS ₹22,709.0 Cr -0.7% -6.1% 10.5% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹108,556.0 Cr -3% 0.6% 21.9% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹96,336.2 Cr -4.9% -6.2% 4% Stock Analytics
FORTIS HEALTHCARE ₹63,390.1 Cr -4.5% -8.6% 36.7% Stock Analytics
NARAYANA HRUDAYALAYA ₹34,108.8 Cr -5% -10.5% 8.8% Stock Analytics
GLOBAL HEALTH ₹28,800.9 Cr -1.6% -6.5% -10.1% Stock Analytics


DR LAL PATHLABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DR LAL PATHLABS

-0.7%

-6.1%

10.5%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses